Form 4 for CVS CVS Health
Accepted 2025-03-18 00:00:00 ET · period of report 2025-03-17 · accession 0001127602-25-009804 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-18 | 2025-03-17 | CVS | Shah Prem S | EVP, Group Pres | M - OptEx | $62.21 | +846 | 43.2K | +2% | +$52.6K |
| D | 2025-03-18 | 2025-03-17 | CVS | Shah Prem S | EVP, Group Pres | M - OptEx | $0.00 | -846 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-17 | M | A | 846 | $62.21 | 43,189.68 | D | — | — | |
| 2 | Derivative | Stock Option | 2025-03-17 | M | D | 846 | $0.00 | 0 | D | $62.21 · 2019-04-01 to 2025-04-01 | 846 Common Stock | (F1) Option became exercisable in four equal installments commencing 04/01/2019. Upon exercise the reporting person retained all shares. All other options from this award were previously exercised. |